options in unresectable hcc
Published 7 years ago • 250 plays • Length 4:26Download video MP4
Download video MP3
Similar videos
-
2:24
emerging i-o combination trials in unresectable hcc
-
4:25
imbrave150 in unresectable hcc
-
7:37
lenvatinib as up-front therapy for unresectable hcc
-
59:57
exploring new treatment options in hcc
-
1:38
dr. ioannou on treatment options in hepatocellular carcinoma
-
6:54
upfront lenvatinib in unresectable hcc
-
4:56
himalaya: tremelimumab durvalumab in unresectable hcc
-
5:57
treatment options for locally advanced hcc
-
1:41
dr. armaghany on frontline sorafenib versus lenvatinib in unresectable hcc
-
1:34
emerald-1: durvalumab, bevacizumab and tace in unresectable hcc
-
8:43
hepatocellular carcinoma: antiangiogenic therapy options
-
7:29
understanding how best to sequence in advanced hcc
-
1:36
dr. abou-alfa discusses new treatment options in hcc
-
5:41
locoregional therapy options in hcc
-
1:18
dr. kaubisch on treatment options for hcc
-
1:04
dr. lee on trial data evaluating the atezolizumab/bevacizumab in unresectable hcc
-
2:52
refine: a real-world analysis of regorafenib in patients with unresectable hcc
-
6:03
two options for checkpoint inhibition in hcc
-
1:15
dr. huey on the importance of patient selection in hcc